부산대학교 도서관

Collin, S ; Tse, J ; Shaikh, NF ; Near, A ; Hamilton, E ; Brufsky, A ; Gradishar, W ; Mehta, S ; Long, GH ; Toms, N

In Value in Health June 2024 27(6) Supplement:S134-S134

Mayer EL; Dana-Farber Cancer Institute, Boston, USA. Electronic address: erica_mayer@dfci.harvard.edu.; Bidard FC; Institut Curie, Paris, France.; Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Janni W; Universitätsklinikum Ulm, Ulm, Germany.; Ma C; Washington University School of Medicine, Saint Louis, USA.; Cristofanilli M; Weill-Cornell Medicine/New York-Presbyterian Hospital, New York, USA.; Iwata H; Nagoya City University, Nagoya, Japan.; Bianchini G; IRCCS Ospedale San Raffaele, Milan, Italy.; Kalinsky K; Winship Cancer Institute, Atlanta, Canada.; Chia S; BC Cancer Agency, Vancouver, Canada.; Brufsky A; UMPC Magee-Womens Hospital, Pittsburgh, USA.; Fasching PA; University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; Nowecki Z; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Warsaw, Poland.; Chen SC; Chang Gung Medical Foundation Linkou Branch, Taoyuan City, Taiwan.; Pascual J; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain.; Moreau L; Pôle Santé République, Clermont-Ferrand, France.; Ruiz-Borrego M; Hospital Universitario Virgen del Rocio, Seville, Spain.; Shai A; Oncology Wing, RAMBAM Health Care Campus, Haifa, Israel.; Karadurmus N; Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.; Sohn JH; Yonsei University, Seoul, Republic of Korea.; Zhu Y; Evinova, Oncology R&D, AstraZeneca, Waltham, USA.; Leddin I; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Miralles MS; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Bartlett CH; Late Development, Oncology R&D, AstraZeneca, Gaithersburg, USA.; Turner N; Royal Marsden Hospital, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Rugo HS; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte. Electronic address: hrugo@coh.org.; Layman RM; The University of Texas MD Anderson Cancer Center, Houston, USA.; Lynce F; Dana-Farber Cancer Institute, Boston, USA.; Liu X; Pfizer Inc., New York, USA.; Li B; Pfizer Inc., New York, USA.; McRoy L; Pfizer Inc., New York, USA.; Cohen AB; Flatiron Health Inc., New York, USA; NYU Langone School of Medicine, New York, USA.; Estevez M; Flatiron Health Inc., New York, USA.; Curigliano G; European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Brufsky A; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Rugo HS; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte. Electronic address: hrugo@coh.org.; Layman RM; The University of Texas MD Anderson Cancer Center, Houston, USA.; Lynce F; Dana-Farber Cancer Institute, Boston, USA.; Liu X; Pfizer Inc., New York, USA.; Li B; Pfizer Inc., New York, USA.; McRoy L; Pfizer Inc., New York, USA.; Cohen AB; Flatiron Health Inc., New York, USA; NYU Langone School of Medicine, New York, USA.; Estevez M; Flatiron Health Inc., New York, USA.; Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Brufsky A; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; In Process

Tarantino P; Department of Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Oncology, Harvard Medical School, Boston, USA; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. Electronic address: paolo_tarantino@dfci.harvard.edu.; Rugo HS; Department of Oncology, University of California, San Francisco Comprehensive Cancer Center, San Francisco, USA.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; Department of Oncology, European Institute of Oncology IRCCS, Milan, Italy.; O'Shaughnessy JA; Department of Oncology, Texas Oncology/Baylor University Medical Center, Dallas, USA.; Janni W; Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany.; Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA.; Mouabbi J; Department of Oncology, MD Anderson Cancer Center, Houston, USA.; Brufsky A; Department of Oncology, University of Pittsburgh, Pittsburgh, USA.; Hamilton E; Department of Oncology, Sarah Cannon Research Institute, Nashville, USA.; O'Regan R; Department of Oncology, University of Rochester, Rochester, USA.; Santarsiero L; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA.; Akdere M; Department of Oncology, Novartis Pharma AG, Basel, Switzerland.; Ye F; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA.; Scotchmer A; Department of Oncology, Novartis Pharmaceuticals UK Limited, London, UK.; Graff SL; Department of Oncology, Brown University Health, Legorreta Cancer Center at Brown University, Providence, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Brufsky, A; Kim, SB; Zvirbule, Z; Eniu, A; Mebis, J; Sohn, JH; Wongchenko, M; Chohan, S; Amin, R; Yan, Y; McNally, V; Miles, D; Loi, S

Annals of Oncology. 32:652-660

Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. Electronic address: hope.rugo@ucsf.edu.; Layman RM; The University of Texas MD Anderson Cancer Center, Houston, USA.; Lynce F; Dana-Farber Cancer Institute, Boston, USA.; Liu X; Pfizer Inc., New York, USA.; Li B; Pfizer Inc., New York, USA.; McRoy L; Pfizer Inc., New York, USA.; Cohen AB; Flatiron Health Inc., New York, USA; NYU Langone School of Medicine, New York, USA.; Estevez M; Flatiron Health Inc., New York, USA.; Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Brufsky A; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Schroeder, B; Zhang, Y; Stal, O; Fornander, T; Brufsky, A; Sgroi, DC; Schnabel, CA

NPJ BREAST CANCER. 3

Yardley, D A; Coleman, R; Conte, P; Cortes, J; Brufsky, A; Shtivelband, M; Young, R; Bengala, C; Ali, H; Eakel, J

Annals of Oncology. Aug2018, Vol. 29 Issue 8, p1763-1770. 8p. 2 Charts, 2 Graphs.

van Londen, G; Beckjord, EB; Dew, MA; Cuijpers, P; Tadic, S; Brufsky, A

Breast Cancer Management. January, 2013, Vol. 2 Issue 1, p71, 11 p.

Goetz MP; Department of Oncology, Mayo Clinic, Rochester. Electronic address: goetz.matthew@mayo.edu.; Bagegni NA; Division of Oncology, Washington University School of Medicine, St. Louis, USA.; Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Brufsky A; University of Pittsburgh Medical Center-Magee Women's Hospital, Pittsburgh.; Cristofanilli MA; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York.; Damodaran S; The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston.; Daniel BR; Tennessee Oncology, Chattanooga.; Fleming GF; The University of Chicago Medical Center, Chicago.; Gradishar WJ; Division of Hematology/Oncology, Northwestern University, Chicago.; Graff SL; Lifespan Cancer Institute/Legorreta Cancer Center at Brown University, Providence.; Grosse Perdekamp MT; Carle Cancer Center, Carle Foundation Hospital, Urbana.; Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville.; Lavasani S; Division of Hematology and Medical Oncology, UC Irvine, Orange.; Moreno-Aspitia A; Division of Hematology/Oncology, Mayo Clinic, Jacksonville.; O'Connor T; Roswell Park Comprehensive Cancer Center, Department of Medicine, Buffalo.; Pluard TJ; Saint Luke's Cancer Institute, Kansas City.; Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco, San Francisco.; Sammons SL; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Schwartzberg LS; Pennington Cancer Institute, University of Nevada, Reno.; Stover DG; Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus.; Vidal GA; Breast Oncology Division, West Cancer Center, Memphis.; Wang G; Medical Oncology, Miami Cancer Institute at Baptist Health, Miami, USA.; Warner E; Division of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Yerushalmi R; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel-Aviv University, Tel-Aviv, Israel.; Plourde PV; Sermonix Pharmaceuticals, Columbus, USA.; Portman DJ; Sermonix Pharmaceuticals, Columbus, USA.; Gal-Yam EN; Breast Oncology Institute, Sheba Medical Center, Ramat Gan, Israel.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Heather_Parsons@dfci.harvard.edu.; Blewett T; Broad Institute of MIT and Harvard, Cambridge.; Chu X; Data Science, Dana-Farber Cancer Institute, Boston.; Sridhar S; Broad Institute of MIT and Harvard, Cambridge.; Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston.; Xiong K; Broad Institute of MIT and Harvard, Cambridge.; Abramson VG; Vanderbilt-Ingram Cancer Center, Nashville.; Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston.; Cheng J; Broad Institute of MIT and Harvard, Cambridge.; Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh.; Rhoades J; Broad Institute of MIT and Harvard, Cambridge.; Force J; Duke Cancer Center, Durham.; Liu R; Broad Institute of MIT and Harvard, Cambridge.; Traina TA; Memorial Sloan Kettering Cancer Center, New York.; Carey LA; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill.; Rimawi MF; Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston.; Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis.; Stearns V; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.; Specht J; Seattle Cancer Care Alliance, Seattle.; Falkson C; The University of Alabama at Birmingham, Birmingham.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.; Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.; Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.; Tayob N; Data Science, Dana-Farber Cancer Institute, Boston.; Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.; Makrigiorgos GM; Radiation Oncology, Dana-Farber Cancer Institute, Boston, USA.; Golub TR; Broad Institute of MIT and Harvard, Cambridge.; Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Erica_Mayer@dfci.harvard.edu.; Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge. Electronic address: viktor@broadinstitute.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: jhaverik@mskcc.org.; Eli LD; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wildiers H; University Hospitals Leuven, Leuven, Belgium.; Hurvitz SA; David Geffen School of Medicine, UCLA, Los Angeles, Santa Monica, USA.; Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Unni N; UT Southwestern Medical Center, Dallas.; Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh.; Park H; Washington University School of Medicine, St. Louis.; Waisman J; City of Hope Comprehensive Cancer Center, Duarte.; Yang ES; University of Alabama at Birmingham, Birmingham, USA.; Spanggaard I; Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark.; Reid S; Division of Hematology/Oncology (Breast Oncology), The Vanderbilt-Ingram Cancer Center, Nashville.; Burkard ME; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.; Vinayak S; Seattle Cancer Care Alliance, Seattle, USA.; Prat A; Hospital Clínic de Barcelona, Barcelona, Spain.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif.; Bidard FC; Department of Medical Oncology, UVSQ/Paris-Saclay University, Institut Curie, Saint Cloud, France.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Crown J; St. Vincent's University Hospital, Dublin, Ireland.; Bhave M; Department of Hematology/Oncology, Emory University, Winship Cancer Institute, Atlanta.; Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston.; Suga JM; Kaiser Permanente, Department of Medical Oncology, Vallejo, USA.; Chia S; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.; Saura C; Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Garcia-Saenz JÁ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid.; Gambardella V; Hospital Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia.; de Miguel MJ; START Madrid - Hospital Universitario Madrid Sanchinarro, Madrid, Spain.; Gal-Yam EN; Institute of Breast Oncology, Sheba Medical Center, Ramat Gan.; Rapael A; Sourasky Medical Center, Tel Aviv.; Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Tel Aviv University, Tel Aviv, Israel.; Ma C; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Hanker AB; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Ye D; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Goldman JW; UCLA Hematology & Oncology, Santa Monica.; Bose R; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Peterson L; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Bell JSK; Tempus Labs, Chicago, USA.; Frazier A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; DiPrimeo D; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wong A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Barcenas, C H; Hurvitz, S A; Di Palma, J A; Bose, R; Chien, A J; Iannotti, N; Marx, G; Brufsky, A; Litvak, A; Ibrahim, E; Alvarez, R H; Ruiz-Borrego, M; Chan, N; Manalo, Y; Kellum, A; Trudeau, M; Thirlwell, M; Garcia Saenz, J; Hunt, D; Bryce, R; McCulloch, L; Rugo, H S; Tripathy, D; Chan, A; CONTROL Study Investigators

RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
instname

Redinbaugh EM; Schuerger JM; Weiss LL; Brufsky A; Arnold R; Redinbaugh, E M; Schuerger, J M; Weiss, L L; Brufsky, A; Arnold, R

Psycho-Oncology. May/Jun2001, Vol. 10 Issue 3, p187-198. 12p.

Peters, D G; Kassam, A B; Feingold, E; Heidrich-O'Hare, E; Yonas, H; Ferrell, R E; Brufsky, A

Stroke (00392499); 2001 Apr, Vol. 32 Issue 4, p1036-1042, 7p

Overmoyer, B; Brufsky, A; Volck, B; Leach, D; Oestergaard, A

In EJC Supplements 2004 2(3):135-135

Mamounas EP; NSABP Foundation and; Department of Surgery, Orlando Health UF Health Cancer Center, Orlando, USA. Electronic address: terry.mamounas@orlandohealth.com.; Untch M; AGO-B and Department of Gynecologic Oncology, HELIOS Klinikum Berlin Buch, Berlin, Germany.; Mano MS; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.; Huang CS; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Geyer CE Jr; NSABP Foundation and; NSABP Foundation and Department of Internal Medicine, Division of Hematology and Medical Oncology, Houston Methodist Cancer Center, Houston, USA.; von Minckwitz G; GBG, Neu-Isenburg, Germany.; Wolmark N; NSABP Foundation and; NSABP Foundation and Department of Surgery, The University of Pittsburgh, Pittsburgh, USA.; Pivot X; ICANS, Strasbourg, France.; Kuemmel S; Breast Unit Kliniken Essen-Mitte, Essen, Germany; Klinik für Gynäkologie mit Brustzentrum Charité-Universitätsmedizin Berlin, Berlin, Germany.; DiGiovanna MP; Yale University School of Medicine, Yale Cancer Center and Smilow Cancer Hospital, New Haven, USA.; Kaufman B; Oncology Division, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Kunz G; GBG, Neu-Isenburg, Germany; St. Johannes Hospital Dortmund, Dortmund, Germany.; Conlin AK; NSABP Foundation and; NSABP Foundation and Department of Medical Oncology, Providence Cancer Institute, Portland, USA.; Alcedo JC; Department of Clinical Oncology, Centro Hemato Oncologico, Panama City, Panama.; Kuehn T; AGO-B and Klinikum Esslingen, Esslingen, Germany.; Wapnir I; NSABP Foundation and; NSABP Foundation and Stanford University School of Medicine, Stanford, USA.; Fontana A; Division of Medical Oncology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; Hackmann J; GBG, Neu-Isenburg, Germany; Marien-Hospital Witten, SEG, Witten, Germany.; Polikoff J; NSABP Foundation and; NSABP Foundation and Department of Hematology/Oncology, Kaiser Permanente, San Diego, USA.; Saghatchian M; Breast Cancer Department, Institut Gustave Roussy, Villejuif, France.; Brufsky A; NSABP Foundation and; NSABP Foundation and Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA.; Yang Y; Division of Hematology-Oncolog, Taichung Veterans General Hospital and School of Medicine, China Medical University, Taichung City, Taiwan.; Zimovjanova M; Department of Oncology, Charles University and General University Hospital, Prague, Czech Republic.; Boulet T; Department of Biostatistics, F. Hoffmann-La Roche, Basel, Switzerland.; Liu H; Product Development Safety, Genentech, Inc., South San Francisco, USA.; Tesarowski D; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Lam LH; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Song C; Product Development Oncology, Genentech, Inc., South San Francisco, USA.; Smitt M; Product Development Oncology, Genentech, Inc., South San Francisco, USA; Seattle Genetics, South San Francisco, USA.; Loibl S; GBG, Neu-Isenburg, Germany; Center for Haematology and Oncology Bethanien, Frankfurt, Germany.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Greenspan SL; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA. greenspn@pitt.edu.; Vujevich KT; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Brufsky A; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Lembersky BC; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; van Londen GJ; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Jankowitz RC; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Puhalla SL; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Rastogi P; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Perera S; Department of Medicine, University of Pittsburgh, 3471 Fifth Ave., Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA.; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.

Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE

Barcenas CH; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: chbarcenas@mdanderson.org.; Hurvitz SA; University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA.; Di Palma JA; University of South Alabama College of Medicine, Mobile, USA.; Bose R; Washington University School of Medicine, St Louis, USA.; Chien AJ; University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.; Iannotti N; Hematology Oncology Associates of the Treasure Coast, Port St. Lucie, USA.; Marx G; Adventist Health Care, Wahroonga, Australia.; Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh, USA.; Litvak A; Saint Barnabas Medical Center, Livingston, USA.; Ibrahim E; Redlands Community Hospital, Redlands, USA.; Alvarez RH; Southeastern Regional Medical Center, Inc., Newnan, USA.; Ruiz-Borrego M; Hospital Universitario Virgen del Rocio, Sevilla, Spain.; Chan N; Rutger Cancer Institute of New Jersey, New Brunswick, USA.; Manalo Y; Coastal Bend Cancer Center, Corpus Christi, USA.; Kellum A; North Mississippi Medical Center Hematology and Oncology Clinic, Tupelo, USA.; Trudeau M; Sunnybrook Research Institute, Toronto, Canada.; Thirlwell M; McGill University Health Centre, Montreal, Canada.; Garcia Saenz J; Hospital Clínico San Carlos, Madrid, Spain.; Hunt D; Puma Biotechnology Inc., Los Angeles, USA.; Bryce R; Puma Biotechnology Inc., Los Angeles, USA.; McCulloch L; Puma Biotechnology Inc., Los Angeles, USA.; Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.; Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, USA.; Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, WA, Australia.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE